NASDAQ:GTH Genetron (GTH) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.02▼$4.0550-Day Range$3.85▼$4.0352-Week Range$2.08▼$4.05Volume412,600 shsAverage Volume51,662 shsMarket Capitalization$127.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOwnershipShort InterestTrendsStock AnalysisHeadlinesOwnershipShort InterestTrends Get Genetron alerts: Email Address Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. About Genetron Stock (NASDAQ:GTH)Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.Read More Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE GTH Stock News HeadlinesMarch 29, 2024 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Announces Completion of Going Private TransactionMarch 28, 2024 | globenewswire.comGenetron Health Announces Completion of Going Private TransactionJuly 27, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.February 21, 2024 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | finance.yahoo.comGenetron Health Announces Shareholders’ Approval of Merger AgreementFebruary 21, 2024 | globenewswire.comGenetron Health Announces Shareholders' Approval of Merger AgreementFebruary 14, 2024 | fool.comGenetron (NASDAQ: GTH)February 14, 2024 | wsj.comGenetron Holdings Ltd. ADRJuly 27, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.January 17, 2024 | finance.yahoo.comGenetron Health to Hold Extraordinary General Meeting of ShareholdersJanuary 9, 2024 | seekingalpha.comAlbertsons-Kroger And 15 Other Merger Arbitrage Opportunities With Wide SpreadsJanuary 9, 2024 | seekingalpha.comGenetron Holdings' Enticing Arbitrage ReturnNovember 24, 2023 | morningstar.comGenetron Holdings Ltd ADR GTHOctober 12, 2023 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Enters into Definitive Merger Agreement for Going Private TransactionOctober 12, 2023 | msn.comStocks Rise Before the Open as U.S. Inflation Data LoomsOctober 12, 2023 | msn.comStocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data LoomsOctober 11, 2023 | finance.yahoo.comGenetron Health Enters into Definitive Merger Agreement for Going Private TransactionMay 24, 2023 | msn.comGenetron Health receives Nasdaq notice for non-complianceSee More Headlines Receive GTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/23/2021Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolNASDAQ:GTH CUSIPN/A CIK1782594 Webwww.genetronhealth.com Phone86-10-5090-7500FaxN/AEmployees993Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$94.34 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$2.63 per share Price / Book1.53Miscellaneous Outstanding Shares31,620,000Free FloatN/AMarket Cap$127.43 million OptionableNot Optionable Beta0.51 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Sizhen Wang (Age 47)Co-Founder, CEO & Chairman Dr. Wei-Wu He Ph.D. (Age 59)Co-Founder & Chairman Emeritus Dr. Hai Yan M.D. (Age 56)Ph.D., Co-Founder, Chief Scientific Officer & Director Mr. Ce Xu (Age 42)Chief Financial Officer Ms. Victoria LeiChief Operating OfficerDr. Yuchen Jiao M.D. (Age 46)Ph.D., Chief Technology Officer Mr. Yong Liang (Age 50)Chief Human Resources Officer Dr. Yun-Fu Hu Ph.D. (Age 61)Chief Medical Officer Ms. Lily LiuChief Commercial OfficerMore ExecutivesKey CompetitorsPersonalisNASDAQ:PSNLBurning Rock BiotechNASDAQ:BNRBiodesixNASDAQ:BDSXbioAffinity TechnologiesNASDAQ:BIAFWPrenetics GlobalNASDAQ:PRENWView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 30,385 shares on 5/20/2024Ownership: 0.096%Black Maple Capital Management LPBought 137,054 shares on 5/16/2024Ownership: 0.933%View All Institutional Transactions GTH Stock Analysis - Frequently Asked Questions How were Genetron's earnings last quarter? Genetron Holdings Limited (NASDAQ:GTH) issued its earnings results on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.30. The company had revenue of $14.05 million for the quarter. Read the conference call transcript. When did Genetron's stock split? Shares of Genetron reverse split on the morning of Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. When did Genetron IPO? Genetron (GTH) raised $162 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 13,000,000 shares at $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers. This page (NASDAQ:GTH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetron Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.